Innovations In Clinical Neuroscience

Pain Management August 2016

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link:

Contents of this Issue


Page 26 of 35

Hot Topics in Pain Management [August 2016] 27 News & Trends Latest news updates in breast cancer research SPINAL STIMULATOR DEVICES BECOMING MORE VERSATILE Innovation in the design of spinal cord stimulators for control of chronic pain syndromes includes wireless devices to eliminate surgical implantation of the battery and devices with high frequency conduction to reduce paresthesias, according to an update at the Pain Care for Primary Care meeting. * For more information, visit pecialty-focus/pain/single-article- page/spinal-stimulator-devices- becoming-more- versatile/4a5eb37b096ae41b8d0260e 32946b965.html KETAMINE COULD TREAT CHRONIC PAIN Using ketamine to treat chronic pain following surgery is a cheaper and safer alternative to commonly prescribed conventional painkillers, according to new research. * For more information, visit th/article/2016/05/30/ketamine-could- treat-chronic-pain 5 MYTHS ABOUT THE CDC OPIOID GUIDELINES In a recent survey of nearly 2,000 pain patients, over two-thirds said their opioid medication has either been reduced or stopped by their doctor since the CDC's opioid prescribing guidelines were released. * For more information, visit ies/2016/8/15/5-myths-about-the-cdc- opioid-guidelines PAIN DOCTORS: INSURANCE COMPANIES WON'T COVER THE ALTERNATIVES TO OPIOIDS Though the increased focus on pain treatment resulted in increases in opioid prescriptions in most doctors initially, for years now, pain specialists have advocated using alternative treatments to alleviate their patients' chronic pain. There's one problem: Health-insurance companies are increasingly cutting reimbursements for these alternative treatments or not covering them at all. * For more information, visit doctors-insurance-companies-wont- 214800636.html CHRONIC PAIN MORE COMMON IN PARTNERS OF DEPRESSED INDIVIDUALS Chronic pain and depression are both common and debilitating conditions. As researchers continue to investigate them, links between the two are becoming clearer. New findings might help move toward effective treatments for both in the future. * For more information, visit ticles/312372.php FDA-APPROVED NERVE ABLATION PROCEDURE MAY OFFER NEW TREATMENT OPTION FOR LOW BACK PAIN A minimally invasive, nerve ablating procedure, recently cleared by the Food and Drug Administration, may give some people with chronic low back pain a new treatment option. * For more information, visit approved-nerve-ablation-procedure- may-offer-new-treatment-option-for- low-back-pain.aspx FDA PANEL RECOMMENDS APPROVAL OF EGALET ABUSE- DETERRENT OPIOID U.S. advisers voted overwhelmingly Thursday to recommend approval of a Wayne, Pennsylvania, company's opioid prescription painkiller formulated to make it harder to tamper with to get a quick high. * For more information, visit 06/business/74869394_1_fda-panel- morphine-the-fda FOR PATIENTS IN CHRONIC PAIN, MEDICAL MARIJUANA NEEDS ROBUST CLINICAL RESEARCH As a therapy, cannabis is becoming more widely prescribed. Most importantly, it has emerged as a topic of debate in terms of policy- making, policing, health risks and even municipal zoning. * For more information, nion/for-patients-in-chronic-pain- medical-marijuana-needs-robust- clinical-research/article31348592/ DEA DECLINES REQUEST TO RECLASSIFY MARIJUANA, CITING ITS 'HIGH POTENTIAL FOR ABUSE' The Drug Enforcement Agency (DEA) has declined two petitions to reclassify marijuana from a Schedule I controlled substance under the Controlled Substances Act (CSA), noting that cannabis "does not have N e w s & Tr e n d s E x p l o r i n g P a i n M a n a g e m e n t i n t h e M e d i a Click * at the end of each summary to access the full news item online.

Articles in this issue

Links on this page

Archives of this issue

view archives of Innovations In Clinical Neuroscience - Pain Management August 2016